Valuation: SWK Holdings Corporation

Market Cap 19Cr 17Cr 16Cr 15Cr 27Cr 1.84TCr 27Cr 190.74Cr 74Cr 941.72Cr 72Cr 71Cr 3.03TCr P/E 2024
14.7x
P/E 2025 -81.9x
Enterprise Value 18Cr 15Cr 15Cr 13Cr 25Cr 1.69TCr 25Cr 174.76Cr 68Cr 862.84Cr 66Cr 65Cr 2.77TCr EV / Sales 2024
8.06x
EV / Sales 2025 5.11x
Free-Float
96.8%
Yield 2024 *
-
Yield 2025 -
6 months-5.19%
Current year-7.56%
Current year 15.71
Extreme 15.71
17.63
1 year 14.21
Extreme 14.21
17.9
3 years 13.17
Extreme 13.17
20.49
5 years 13.17
Extreme 13.17
20.49
10 years 0
Extreme 0
20.49
Date Insider Type Main position Quantity % Market Cap. Importance
06/04/26
Carlson Capital LP
OthersCompany 3,47,12,035 -
16/06/25 Free

Director

3,858 0.0315%
16/06/25 Free

Director

3,858 0.0315%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+9.50%+1.15% 19Cr
+0.95%-1.85%+11.85%+31.16% 1.23TCr
-0.40%-2.01%-17.70%+41.78% 1.17TCr
+0.11%+0.81%-36.34%+6.46% 1.09TCr
+1.52%+0.79%-18.08%+15.52% 845.58Cr
+0.71%-6.05%+15.06%+128.02% 733.5Cr
+0.21%-4.49%-33.79%+20.82% 658.29Cr
-0.93%-4.46%-7.51%-36.03% 586.58Cr
0.00%-0.28%+18.24%+12.54% 555.56Cr
Average +0.24%-3.11%-6.53%+24.60% 764.9Cr
Weighted average by Cap. +0.32%-2.42%-9.61%+29.16%

Financials

2024 2025
Net sales 2.75Cr 2.42Cr 2.28Cr 2.08Cr 3.89Cr 264.01Cr 3.92Cr 27Cr 11Cr 134.88Cr 10Cr 10Cr 433.49Cr 3.76Cr 3.3Cr 3.11Cr 2.84Cr 5.31Cr 360.22Cr 5.35Cr 37Cr 14Cr 184.03Cr 14Cr 14Cr 591.45Cr
Net income 1.35Cr 1.18Cr 1.12Cr 1.02Cr 1.91Cr 129.28Cr 1.92Cr 13Cr 5.18Cr 66Cr 5.06Cr 4.95Cr 212.26Cr -25.33L -22.23L -20.99L -19.13L -35.81L -24Cr -36.07L -2.51Cr -97.3L -12Cr -95.1L -93.05L -40Cr
Net Debt 2.8Cr 2.45Cr 2.32Cr 2.11Cr 3.95Cr 267.89Cr 3.98Cr 28Cr 11Cr 136.86Cr 10Cr 10Cr 439.84Cr -1.61Cr -1.41Cr -1.34Cr -1.22Cr -2.28Cr -154.41Cr -2.29Cr -16Cr -6.19Cr -79Cr -6.05Cr -5.92Cr -253.52Cr
Logo SWK Holdings Corporation
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
Employees
9
  1. Stock Market
  2. Stocks
  3. SWKH Stock